MétaCan
Menu
Back to cohort

Assessing disparities in real-world overall survival (rwOS) among sociodemographic groups in advanced ovarian cancer (aOC): The impact of biomarker testing and first-line (1L) maintenance therapies (mtx).

2025· article· en· W4414893408 on OpenAlexaff
Bhavana Pothuri, Linlin Luo, Jasmine Sze, Zulikhat Segunmaru, Aaron Springford

Bibliographic record

VenueJCO Oncology Practice · 2025
Typearticle
Languageen
FieldMedicine
TopicOvarian cancer diagnosis and treatment
Canadian institutionsAstraZeneca (Canada)
Fundersnot available
KeywordsBiomarkerSocioeconomic statusCohortProportional hazards modelHazard ratioCohort studyOvarian cancerLogistic regressionObservational study

Abstract

fetched live from OpenAlex

217 Background: Sociodemographic inequities in aOC survival have been documented and are thought to be largely the result of unequal access to guideline recommended care. In a previous phase of this study with a similar cohort of patients (pts), results showed lower rates of biomarker testing and use of 1L mtx in some socioeconomic status (SES) and racial groups. This study aims to evaluate the association between pts and clinical characteristics on rwOS in aOC. We also estimate how much of the association between race or SES and rwOS is due to biomarker testing and 1L mtx. Methods: An observational cohort study of US pts with newly diagnosed aOC was conducted between 1 Jan 2019 and 30 Dec 2023 using retrospective clinical data from the nationwide Flatiron Health electronic health record-derived deidentified database. Cox regression was used to assess associations between pts and clinical characteristics and rwOS from time of diagnosis, and between biomarker status and receipt of 1L mtx and rwOS. Mediation analysis was used to estimate indirect effects of differences in the probability of receiving recommended biomarker testing and 1L mtx (defined as pts who had known homologous recombination deficiency [HRD] or BRCA status and received a PARP inhibitor [PARPi] if BRCA mutation [BRCAm] or HRD-positive) on rwOS due to race (non-white vs white) and SES (1 [low] vs 2, 3, 4, 5 or unknown). Results: 1287 pts were included in the cohort; median age 68 years (range 22–85); 61% of pts were of white race and 39% non-white; 12% of pts SES 1, 15% SES 2, 21% SES 3, 22% SES 4, 23% SES 5, and 7% SES unknown. Eighty-eight percent of pts received BRCA testing and 49% HRD testing (including BRCAm); 30% (n = 392) received 1L PARPi mtx. Younger age, FIGO stage III, Eastern Cooperative Oncology Group 0, serous histology, and receipt of surgery were all associated with improved rwOS. Receipt of biomarker testing and 1L mtx also had a strong association with improved rwOS. In the mediation analysis, the indirect effect of race through receipt of biomarker testing and 1L mtx was statistically significant and accounted for most of the difference in rwOS between white and non-white pts (Table). Conclusions: Lower rates of BRCA and HRD testing and 1L mtx were associated with worse rwOS. Much of the association in disparities in rwOS by race or SES was due to differences in modifiable risk factors related to biomarker testing and treatment patterns. This suggests that mitigating these differences has the potential to improve outcomes in non-white and lower SES pts with aOC. Effect of race or SES on median rwOS (95% CI), months. Indirect effect via BT + 1L mtx Direct effect other than BT + 1L mtx Total Race non-white −1.7 (−3.6, −0.1) −0.8 (−8.1, 6.6) −2.5 (−9.6, 5.0) SES 1 (low) −1.5 (−3.6, 0.4) −2.0 (−11.3, 8.7) −3.4 (−12.8, 7.3) BT, biomarker testing.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.028
Threshold uncertainty score0.969

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.001
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.052
GPT teacher head0.412
Teacher spread0.360 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJCO Oncology PracticeSame topicOvarian cancer diagnosis and treatmentFrench-language works237,207